Moore Tara L, Pessina Monica A, Finklestein Seth P, Kramer Brian C, Killiany Ronald J, Rosene Douglas L
Department of Anatomy & Neurobiology, Boston University School of Medicine , Boston, MA , USA .
Somatosens Mot Res. 2013 Dec;30(4):185-96. doi: 10.3109/08990220.2013.790806. Epub 2013 Jun 12.
We investigated the efficacy on recovery of function following controlled cortical ischemia in the monkey of the investigational cell drug product, CNTO 0007. This drug contains a cellular component, human umbilical tissue-derived cells, in a proprietary thaw and inject formulation. Results demonstrate significantly better recovery of motor function in the treatment group with no difference between groups in the volume or surface area of ischemic damage, suggesting that the cells stimulated plasticity.
我们研究了研究性细胞药物产品CNTO 0007对猴子控制性皮质缺血后功能恢复的疗效。这种药物在一种专利的解冻和注射制剂中含有一种细胞成分,即人脐带组织衍生细胞。结果表明,治疗组的运动功能恢复明显更好,而缺血损伤的体积或表面积在各组之间没有差异,这表明这些细胞刺激了可塑性。